Abstract
Polyethylene glycol is a product with many pharmaceutical and industrial uses due to its hydrophilic nature. As a medication, it is part of a laxative class of drugs which is minimally absorbed in gastrointestinal tract increasing osmotic pressure resulting in softening of stools and increased bowel movements. There are certain FDA and non FDA-approved indications for its use. Its main use is for the treatment of constipation, fecal impaction, chronic constipation, and colonoscopy preparation. Its administration is elaborated according to different age groups and indications. Polyethylene glycol is over-the-counter medication as there is easy access to this drug, but as a health care provider, we need to emphasize the directions for its appropriate use with proper counseling regarding the onset of action as well as when to discontinue it which will yield improved patient results while minimizing adverse events.
Reference48 articles.
1. Jang HJ, Sachin CY, Kim KB. Safety evaluation of PEG compounds for cosmetic use. Toxicology Research. 2015;:105-136
2. US Government–Food and Drug Agency. Food Additive Status List. Food and Drug Administration; 2023
3. Polyethylene Glycol as Pharmaceutical Excipient. Available from: [Accessed: April 27, 2021]
4. Ma Y, Ji Y, Zhong T, Wan W, Yang Q, Li A, et al. Bioprinting-based PDLSC-ECM screening for in vivo repair of alveolar bone defect using cell-laden, injectable and photocrosslinkable hydrogels. ACS Biomaterials Science & Engineering. 2017;(12):3534-3545. DOI: 10.1021/acsbiomaterials.7b00601. PMID 33445388
5. Cabanillas B, Akdis CA, Novak N. Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol? Allergy. 2021;(6):1617-1618. DOI: 10.1111/all.14711. PMID 33320974. S2CID 229284320